Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lung neoplasms/muntah

Tautan disimpan ke clipboard
Halaman 1 dari 60 hasil

Safety, Tolerability, PK and PD Following SC PF-06946860 in Patients With NSCLC and Cachexia

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This 12-week open-label study will explore how PF-06946860 is tolerated, the effects of the study drug, the best dose for treatment and how participants with Non Small Cell Lung Cancer and cachexia feel after receiving repeated subcutaneous dosing.During the 12-week treatment period, study drug will

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Surgical resection is the main treatment for patients with non-small cell lung cancer (NSCLC) and continuous efforts have been made to evolve surgical strategies and techniques. It has been now been realized that perioperative period is characterized with profound changes and anesthesia management

Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
On day 1 (day of chemotherapy), all eligible patients will receive oral NEPA (300 mg netupitant/0.5 mg palonosetron), 60 minutes before chemotherapy, and intravenous dexamethasone 12 mg, 30 minutes before chemotherapy initiation. For the prevention of delayed CINV, patients will be assigned randomly

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The combination of Oxaliplatin and Gemcitabine has synergistic effects on a variety of human cancer cell lines in vitro. Clinically, it has demonstrated activity in other malignancies including lung, and pancreas. In the former study, poor prognosis advanced non-small cell lung cancer patients

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar

Dexmedetomidine and Ketamine in VATS Surgery

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Video-assisted thoracic surgery (VATS) for pulmonary resection is associated with less tissue trauma, less impairment in lung function, and reduced postoperative pain compared with thoracotomy, although many patients continue to report significant acute postoperative pain. If not well-controlled,
Better understanding of the role of the immunological system in tumor control has opened multiple doors to implement different strategies to enhance immune response against cancer cells. It is known that tumor cells elude immune response by several mechanisms. The development of monoclonal

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Delirium is an acutely occurred, transient and fluctuating central nervous system dysfunction which is characterized by cognitive dysfunction, decreased level of consciousness, decentralized attention, and/or disturbed perception. It is a common complication in elderly patients after surgery.

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Surgical resection is the first choice treatment for patients with non-small-cell lung cancer. Although improvements of surgical techniques have reduced the incidence of complications, the long-term survival rate of postoperative patient is far from optimal. Cancer metastasis and recurrence are the

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
PRIMARY OBJECTIVES: I. To determine feasibility and safety of long-term administration of two doses of a peripheral opioid receptor antagonist in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line systemic therapy. SECONDARY OBJECTIVES: I. To explore whether patients
Background Therapeutic Information In ovarian cancer, several single agent phase II trials of vinorelbine in recurrent OC have shown variable response rates of 3 - 30%. However, previous studies have involved "all-comers" and no reported trials have selected patients based on confirmed pure HGSOC or
Thoracoscopic minor lung resection has been the reasonable option for the diagnosis and treatment of management of the undetermined peripheral pulmonary nodules. Uniport procedure could reduce postoperative pain score, the length of hospital stay, moreover, nonintubated technique can avoid the

Effects of Methylprednisolone on Immunological Function and Postoperative Adverse Reaction in Patients With Lung Cancer

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
80 cases of patients undergoing general anesthesia during radical resection of lung cancer by thoracoscope, American Society of Anesthesiologists (ASA) physical status II~III, male or female, age between 65 and 85 years old,randomly divided into 2 groups (M and C) ,each group with 40 cases. In group

Study of Ixazomib and Erlotinib in Solid Tumors

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Study Groups: If you are found to be eligible to take part in this study, you will be assigned to a dose level of ixazomib and erlotinib based on when you join this study. Up to 4 dose levels of ixazomib will be tested. Up to 18 participants may be enrolled at each dose level. The first group of

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
Background: Lung cancer is the leading cause of cancer death in Mexico and the world. Malnutrition is often associated with this type of cancer appearing in about 40-50% of patients the diagnosis made, affecting the quality of life and prognosis, as well as increased toxicity to cancer treatment.
Bergabunglah dengan
halaman facebook kami

Database tanaman obat terlengkap yang didukung oleh sains

  • Bekerja dalam 55 bahasa
  • Pengobatan herbal didukung oleh sains
  • Pengenalan herbal melalui gambar
  • Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
  • Baca publikasi ilmiah yang terkait dengan pencarian Anda
  • Cari tanaman obat berdasarkan efeknya
  • Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten

Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan

Google Play badgeApp Store badge